Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy

Abstract Hypertensive nephrosclerosis (HN) and Type 2 diabetic nephropathy (T2DN) are the leading causes of chronic kidney disease (CKD). To explore shared pathogenetic mechanisms, we analyzed transcriptomes of kidney biopsies from patients with HN or T2DN. Total RNA was extracted from 10 μm whole k...

Full description

Bibliographic Details
Main Authors: Ole Petter Nordbø, Lea Landolt, Øystein Eikrem, Andreas Scherer, Sabine Leh, Jessica Furriol, Terje Apeland, Piotr Mydel, Hans‐Peter Marti
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Physiological Reports
Subjects:
Online Access:https://doi.org/10.14814/phy2.15825
_version_ 1797397450804166656
author Ole Petter Nordbø
Lea Landolt
Øystein Eikrem
Andreas Scherer
Sabine Leh
Jessica Furriol
Terje Apeland
Piotr Mydel
Hans‐Peter Marti
author_facet Ole Petter Nordbø
Lea Landolt
Øystein Eikrem
Andreas Scherer
Sabine Leh
Jessica Furriol
Terje Apeland
Piotr Mydel
Hans‐Peter Marti
author_sort Ole Petter Nordbø
collection DOAJ
description Abstract Hypertensive nephrosclerosis (HN) and Type 2 diabetic nephropathy (T2DN) are the leading causes of chronic kidney disease (CKD). To explore shared pathogenetic mechanisms, we analyzed transcriptomes of kidney biopsies from patients with HN or T2DN. Total RNA was extracted from 10 μm whole kidney sections from patients with HN, T2DN, and normal controls (Ctrl) (n = 6 for each group) and processed for RNA sequencing. Differentially expressed (log2 fold change >1, adjusted p < 0.05) genes (DEG) and molecular pathways were analyzed, and selected results were validated by immunohistochemistry (IHC). ELISA on serum samples was performed on a related cohort consisting of patients with biopsy‐proven HN (n = 13) and DN (n = 9), and a normal control group (n = 14). Cluster analysis on RNA sequencing data separated diseased and normal tissues. RNA sequencing revealed that 88% (341 out of 384) of DEG in HN were also altered in T2DN, while gene set enrichment analysis (GSEA) showed that over 90% of affected molecular pathways, including those related to inflammation, immune response, and cell‐cycle regulation, were similarly impacted in both HN and T2DN samples. The increased expression of genes tied to interleukin signaling and lymphocyte activation was more pronounced in HN, while genes associated with extracellular matrix organization were more evident in T2DN. Both HN and T2DN tissues exhibited significant upregulation of genes connected with inflammatory responses, T‐cell activity, and partial epithelial to mesenchymal transition (p‐EMT). Immunohistochemistry (IHC) further confirmed T‐cell (CD4+ and CD8+) infiltration in the diseased tissues. Additionally, IHC revealed heightened AXL protein expression, a key regulator of inflammation and p‐EMT, in both HN and T2DN, while serum analysis indicated elevated soluble AXL levels in patients with both conditions. These findings underline the shared molecular mechanisms between HN and T2DN, hinting at the potential for common therapeutic strategies targeting both diseases.
first_indexed 2024-03-09T01:11:09Z
format Article
id doaj.art-f2b04b1557c248e98bfb3675c6a055b6
institution Directory Open Access Journal
issn 2051-817X
language English
last_indexed 2024-03-09T01:11:09Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series Physiological Reports
spelling doaj.art-f2b04b1557c248e98bfb3675c6a055b62023-12-11T07:16:19ZengWileyPhysiological Reports2051-817X2023-10-011119n/an/a10.14814/phy2.15825Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathyOle Petter Nordbø0Lea Landolt1Øystein Eikrem2Andreas Scherer3Sabine Leh4Jessica Furriol5Terje Apeland6Piotr Mydel7Hans‐Peter Marti8Department of Clinical Medicine University of Bergen Bergen NorwayDepartment of Clinical Medicine University of Bergen Bergen NorwayDepartment of Clinical Science University of Bergen Bergen NorwaySpheromics Kontiolahti FinlandDepartment of Clinical Medicine University of Bergen Bergen NorwayDepartment of Clinical Medicine University of Bergen Bergen NorwayStavanger University Hospital Stavanger NorwayDepartment of Clinical Medicine University of Bergen Bergen NorwayDepartment of Clinical Medicine University of Bergen Bergen NorwayAbstract Hypertensive nephrosclerosis (HN) and Type 2 diabetic nephropathy (T2DN) are the leading causes of chronic kidney disease (CKD). To explore shared pathogenetic mechanisms, we analyzed transcriptomes of kidney biopsies from patients with HN or T2DN. Total RNA was extracted from 10 μm whole kidney sections from patients with HN, T2DN, and normal controls (Ctrl) (n = 6 for each group) and processed for RNA sequencing. Differentially expressed (log2 fold change >1, adjusted p < 0.05) genes (DEG) and molecular pathways were analyzed, and selected results were validated by immunohistochemistry (IHC). ELISA on serum samples was performed on a related cohort consisting of patients with biopsy‐proven HN (n = 13) and DN (n = 9), and a normal control group (n = 14). Cluster analysis on RNA sequencing data separated diseased and normal tissues. RNA sequencing revealed that 88% (341 out of 384) of DEG in HN were also altered in T2DN, while gene set enrichment analysis (GSEA) showed that over 90% of affected molecular pathways, including those related to inflammation, immune response, and cell‐cycle regulation, were similarly impacted in both HN and T2DN samples. The increased expression of genes tied to interleukin signaling and lymphocyte activation was more pronounced in HN, while genes associated with extracellular matrix organization were more evident in T2DN. Both HN and T2DN tissues exhibited significant upregulation of genes connected with inflammatory responses, T‐cell activity, and partial epithelial to mesenchymal transition (p‐EMT). Immunohistochemistry (IHC) further confirmed T‐cell (CD4+ and CD8+) infiltration in the diseased tissues. Additionally, IHC revealed heightened AXL protein expression, a key regulator of inflammation and p‐EMT, in both HN and T2DN, while serum analysis indicated elevated soluble AXL levels in patients with both conditions. These findings underline the shared molecular mechanisms between HN and T2DN, hinting at the potential for common therapeutic strategies targeting both diseases.https://doi.org/10.14814/phy2.15825diabetic nephropathyhypertensive nephropathyinflammationrenal transcriptome
spellingShingle Ole Petter Nordbø
Lea Landolt
Øystein Eikrem
Andreas Scherer
Sabine Leh
Jessica Furriol
Terje Apeland
Piotr Mydel
Hans‐Peter Marti
Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
Physiological Reports
diabetic nephropathy
hypertensive nephropathy
inflammation
renal transcriptome
title Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
title_full Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
title_fullStr Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
title_full_unstemmed Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
title_short Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
title_sort transcriptomic analysis reveals partial epithelial mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and type 2 diabetic nephropathy
topic diabetic nephropathy
hypertensive nephropathy
inflammation
renal transcriptome
url https://doi.org/10.14814/phy2.15825
work_keys_str_mv AT olepetternordbø transcriptomicanalysisrevealspartialepithelialmesenchymaltransitionandinflammationascommonpathogenicmechanismsinhypertensivenephrosclerosisandtype2diabeticnephropathy
AT lealandolt transcriptomicanalysisrevealspartialepithelialmesenchymaltransitionandinflammationascommonpathogenicmechanismsinhypertensivenephrosclerosisandtype2diabeticnephropathy
AT øysteineikrem transcriptomicanalysisrevealspartialepithelialmesenchymaltransitionandinflammationascommonpathogenicmechanismsinhypertensivenephrosclerosisandtype2diabeticnephropathy
AT andreasscherer transcriptomicanalysisrevealspartialepithelialmesenchymaltransitionandinflammationascommonpathogenicmechanismsinhypertensivenephrosclerosisandtype2diabeticnephropathy
AT sabineleh transcriptomicanalysisrevealspartialepithelialmesenchymaltransitionandinflammationascommonpathogenicmechanismsinhypertensivenephrosclerosisandtype2diabeticnephropathy
AT jessicafurriol transcriptomicanalysisrevealspartialepithelialmesenchymaltransitionandinflammationascommonpathogenicmechanismsinhypertensivenephrosclerosisandtype2diabeticnephropathy
AT terjeapeland transcriptomicanalysisrevealspartialepithelialmesenchymaltransitionandinflammationascommonpathogenicmechanismsinhypertensivenephrosclerosisandtype2diabeticnephropathy
AT piotrmydel transcriptomicanalysisrevealspartialepithelialmesenchymaltransitionandinflammationascommonpathogenicmechanismsinhypertensivenephrosclerosisandtype2diabeticnephropathy
AT hanspetermarti transcriptomicanalysisrevealspartialepithelialmesenchymaltransitionandinflammationascommonpathogenicmechanismsinhypertensivenephrosclerosisandtype2diabeticnephropathy